Clinical trials - Press Releases

Date	Title	Company
23-Mar-2020	4D pharma presents additional interim clinical data from combination study for lead oncology candidate	4D
23-Mar-2020	Vectura Group plc: 2019 Preliminary Results	Vectura Group plc
23-Mar-2020	Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine	Pfizer
23-Mar-2020	Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates	Abeona Therapeutics
23-Mar-2020	Inceptua announces global license agreement for the commercialization of JETREA®	Inceptua
20-Mar-2020	EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy announce initiation of an observational case-control study of siltuximab in patients with COVID-19 who have developed serious respiratory complications	EUSA Pharma
19-Mar-2020	Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs	Albumedix Ltd
16-Mar-2020	TIKOMED Secures 5M Euro Funding for the Clinical Development of ILB™ and IBSOLVMIR®	TIKOMED
16-Mar-2020	BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat	BioNTech
16-Mar-2020	GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)	GW Pharmaceuticals plc
16-Mar-2020	Are kidneys targeted by the novel coronavirus?	ERA-EDTA
16-Mar-2020	BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China	BioNTech SE
16-Mar-2020	BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat	BioNTech SE
13-Mar-2020	Urine test could reduce unnecessary prostate cancer biopsies	University of East Anglia
12-Mar-2020	FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)	FSD Pharma
12-Mar-2020	Vifor Pharma Group reports strong growth in 2019, exceeding raised guidance	Vifor Pharma Group
12-Mar-2020	Sareum notes publication of new research highlighting the therapeutic potential of SRA737 in a new drug combination targeting lung and colorectal cancers	Sareum Holdings plc
12-Mar-2020	Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation	Acacia Pharma Group plc
12-Mar-2020	Zelluna Immunotherapy collaborates with Karolinska Institutet and enters into the NextGenNK Competence Center for allogeneic TCR based Natural Killer cell (TCR-NK) therapy development	Zelluna Immunotherapy
12-Mar-2020	Positive results from Swedish study with DiviTum in metastatic breast cancer published in prestigious journal	Biovica